Thrombopénie à l'héparine sous hémodialyse en réanimation : utilisation d'un héparinoïde de bas poids moléculaire, l'ORG 10 172 (Orgaran®)
- 31 December 1995
- journal article
- case report
- Published by Elsevier in Annales Françaises dʼAnesthésie et de Réanimation
- Vol. 14 (1) , 29-32
- https://doi.org/10.1016/s0750-7658(05)80146-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and SafetyChest, 1992
- Use of a Low Molecular Weight Preparation of Heparin — ORG 10172 (Lomoparan) in the Critically IllAnaesthesia and Intensive Care, 1991
- Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopeniaIntensive Care Medicine, 1991
- The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosisAustralian and New Zealand Journal of Medicine, 1991
- “Heparin-free” Cardiopulmonary BypassAnesthesiology, 1990
- Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172Blood, 1989
- ORG 10172: a low molecular weight heparinoid anticoagulant with a long half‐life in man.British Journal of Clinical Pharmacology, 1987
- Heparin-associated thrombocytopenia and thrombosis: A serious clinical problem and potential solutionJournal of Vascular Surgery, 1986
- Hemodialysis Without AnticoagulationAmerican Journal of Kidney Diseases, 1985
- Prostacyclin as the Sole Antithrombotic Agent for Acute Renal Failure HemodialysisNephron, 1983